Fructooligosaccharides (FOS) ： Irritable Bowel Syndrome (IBS)

Q: Does Fructooligosaccharides (FOS) help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Fructooligosaccharides (FOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

Q: How much Fructooligosaccharides (FOS) should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Fructooligosaccharides (FOS) and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

結論

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

Key Study Findings

Other

FODMAP Profile of Wholegrain Pasta.

Dose: None vs: None Outcome: FODMAP compound content in pasta (analytical) 効果: None None

対象集団: Commercially available pasta products (analytical study)

Randomized Controlled Trial n=9 12 weeks

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: …

Dose: None vs: Baseline; crossover between 3 diets Outcome: Birmingham IBS questionnaire symptom score 効果: 75% relief on low FOS+GOS; 62.5% on FODMAP p<0.05

対象集団: IBS patients (Rome IV criteria)

Other

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.

Dose: None vs: Standard wholegrain flour products Outcome: FODMAP content reduction in cookies and crackers 効果: Up to 99.5% FODMAP reduction (wheat malt) None

対象集団: Laboratory food science study (no human subjects)

Randomized Controlled Trial 12 weeks Double-blind

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides …

Dose: None vs: Placebo Outcome: Quality of life 効果: None p = 0.023

対象集団: IBS patients

In Vitro

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions.

Dose: None vs: None Outcome: None 効果: None None

対象集団: None

Controlled Clinical Trial n=54 3.0 weeks

[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with …

Dose: 350 mg vs: None Outcome: IBS symptom improvement 効果: None None

対象集団: Irritable bowel syndrome with diarrhea and antibiotic-associated diarr

Key Statistics

研究数

150

参加者数

↔

Mixed

グレード

Referenced Papers

FODMAP Profile of Wholegrain Pasta. Other

Foods (Basel, Switzerland) 2025 3 件の引用

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers. Other

Foods (Basel, Switzerland) 2025 1 件の引用

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: A Randomised Crossover Study. Other

Gastroenterology research and … 2025

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel … Other

Journal of clinical … 2024 4 件の引用

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions. Other

Frontiers in nutrition 2023 8 件の引用

[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea … Other

Voprosy pitaniia 2023

Inulin as a functional ingredient and their applications in meat products. Review

Carbohydrate polymers 2022 77 件の引用

Increased fermentable carbohydrate intake alters colonic mucus barrier function through glycation processes and increased mast cell counts. Other

FASEB journal : … 2022 16 件の引用

Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of … Other

Journal of clinical … 2022 12 件の引用

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal … RCT

Nutrients 2022 8 件の引用

Current evidence on the therapeutic use of fiber in irritable bowel syndrome. Other

Expert review of … 2022 8 件の引用

Nutritional and anti-nutritional properties of lentil (Lens culinaris) protein isolates prepared by pilot-scale processing. Other

Food chemistry: X 2021 64 件の引用

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction through Fermentation. Other

Foods (Basel, Switzerland) 2021 10 件の引用

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant … RCT

Nutrients 2020 78 件の引用

Impact of Cultivation Method and Cultivar Selection on Soluble Carbohydrates and Pungent Principles in Onions ( Allium cepa L.). Other

Journal of agricultural … 2018 13 件の引用

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double … RCT

Neurogastroenterology and motility 2017 131 件の引用

Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial. RCT

Nutrition journal 2017 10 件の引用

[Contemporary dietotherapy of the irritable bowel syndrome]. Review

Voprosy pitaniia 2013

Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. RCT

The American journal … 2000 136 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:: 2-10 g/day
prebioticeffect:: 5-8 g/day for bifidogenic effect
constipationsupport:: 5-10 g/day

上限量： Well-tolerated up to 20 g/day; start low to avoid excess gas

研究で検討された用量

用量	期間	効果	N
None	--	Neutral	--
None	12 weeks	Positive	9
None	--	Positive	--
None	12 weeks	Positive	--
None	--	Mixed	--
350 mg	3.0 weeks	Positive	54
None	--	Mixed	--
None	--	Negative	--

推奨摂取タイミング： With meals; divide doses throughout the day

Safety & Side Effects

報告されている副作用

⚠ Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
⚠ Abdominal cramping at higher doses
⚠ May worsen IBS symptoms in FODMAP-sensitive individuals
⚠ Loose stools at excessive doses

既知の相互作用

● Other FODMAPs (cumulative fermentation effect in sensitive individuals)
● Blood sugar-lowering medications (FOS may modestly affect glycemic response)
● Calcium supplements (FOS may enhance calcium absorption)

耐容上限摂取量： Well-tolerated up to 20 g/day; start low to avoid excess gas

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Fructooligosaccharides (FOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

How much Fructooligosaccharides (FOS) should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Fructooligosaccharides (FOS) and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

Related Evidence

に関する他の成分： Irritable Bowel Syndrome (IBS)

Peppermint Oil A Lactobacillus rhamnosus GG B Psyllium Husk B Lactobacillus plantarum B Partially Hydrolyzed Guar Gum (PHGG) B Bifidobacterium longum B

Fructooligosaccharides (FOS) 他の症状・状態について

Chronic Constipation C

総合評価

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

Evidence Strength30%

Low confidence

研究の内訳

RCT (5)Meta (0)Other (0)

代替成分との比較

この症状に対する他の成分との比較をご覧ください。

に関するすべての成分を見る： Irritable Bowel Syndrome (IBS)

詳しく見る

FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。